Skip to main content

Advertisement

SpringerLink
Log in

Gene expression profiling of breast cancer

  • Review Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Numerous genes are controlled by complex regulatory networks and involved in the development and progression of breast cancer, and these genes are the key factors determining each characteristic of the tumor. Gene expression profiling, a large scale analysis of gene expression, has created new possibilities for the molecular characterization of cancer. Systematic analysis of expression patterns of thousands of genes in tumor cells using DNA microarrays and correlation of these patterns to specific features of phenotypic variation may provide the basis for an improved taxonomy of cancer. These profiles have the potential to explain the genetic heterogeneity of breast cancer and allow treatment strategies to be planned in accordance with their probability of success in individual patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.J Clin Oncol 21:3357–3365, 2003.

    Article  PubMed  Google Scholar 

  2. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D: National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000.J Natl Cancer Inst 93:979–989, 2001.

    Article  PubMed  CAS  Google Scholar 

  3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, HaugenStrano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barret C, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick M: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science 266:66–71, 1994.

    Article  PubMed  CAS  Google Scholar 

  4. Welcsh PL, Owens KN, King MC: Insights into the functions of BRCA1 and BRCA2.Trends Genet 16:69–74, 2000.

    Article  PubMed  CAS  Google Scholar 

  5. Bieche I, Lidereau R: Genetic alterations in breast cancer.Genes Chromosomes Cancer 14:227–251, 1995.

    Article  PubMed  CAS  Google Scholar 

  6. Steeg PS, Zhou Q: Cyclins and breast cancer.Breast Cancer Res Treat 52:17–28, 1998.

    Article  PubMed  CAS  Google Scholar 

  7. Janicke F, Prechtl A, Thomssen C, Harbeck N, Meisner C, Untch M, Sweep CG, Selbmann HK, Graeff H, Schmitt M; German No Study Group: Randomized adjuvant chemotherapy trial in high-risk, lymph nodenegative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.J Natl Cancer Inst 93:913–920, 2001.

    Article  PubMed  CAS  Google Scholar 

  8. van Diest PJ, Michalides RJ, Jannink L, van der Valk P, Peterse HL, de Jong JS, Meijer CJ, Baak JP: Cyclin Dl expression in invasive breast cancer. Correlations and prognostic value.Am J Pathol 150:705–711, 1997.

    PubMed  Google Scholar 

  9. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyse gene expression patterns in human cancer.Nat Ganet 14:457–460, 1996.

    Article  CAS  Google Scholar 

  10. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.Science 286:531–537, 1999.

    Article  PubMed  CAS  Google Scholar 

  11. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V: Molecular classification of cutaneous malignant melanoma by gene expression profiling.Nature 406:536–540, 2000.

    Article  PubMed  CAS  Google Scholar 

  12. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.Proc Natl Acad Sci USA 96:9212–9217, 1999.

    Article  PubMed  CAS  Google Scholar 

  13. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours.Nature 406:747–752, 2000.

    Article  PubMed  CAS  Google Scholar 

  14. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J: Geneexpression profiles in hereditary breast cancer.N Engl J Med 344:539–548, 2001.

    Article  PubMed  CAS  Google Scholar 

  15. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.Proc Natl Acad Sci USA 98:10869–10874, 2001.

    Article  PubMed  CAS  Google Scholar 

  16. van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer.Nature 415:530–536, 2002.

    Article  Google Scholar 

  17. Early Breast Cancer Trialists’ Collaborative Group: Polychemotherapy for early breast cancer: an overview of the randomised trials.Lancet 352:930–942, 1998.

    Article  Google Scholar 

  18. Early Breast Cancer Trialists’ Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials.Lancet 351:1451–1467, 1998.

    Article  Google Scholar 

  19. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR: Predicting the clinical status of human breast cancer by using gene expression profiles.Proc Natl Acad Sci USA 98:11462–11467, 2001.

    Article  PubMed  CAS  Google Scholar 

  20. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB Jr, Hoehn JL, Lees AW, Dimitrov NV, Bear HD: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.J Clin Oncol 16:2672–2685, 1998.

    PubMed  CAS  Google Scholar 

  21. Rivera E, Holmes FA, Frye D, Valero V, Theriault RL, Booser D, Walters R, Buzdar AU, Dhingra K, Fraschini G, Hortobagyi GN: Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.Cancer 89:2195–2201, 2000.

    Article  PubMed  CAS  Google Scholar 

  22. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B: Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.J Natl Cancer Inst Monogr 30:96–102, 2001.

    PubMed  Google Scholar 

  23. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O’Connell P: Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.Lancet 362:362–369, 2003.

    Article  PubMed  CAS  Google Scholar 

  24. Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K, Lecocke M, Metivier J, Booser D, Ibrahim N, Valero V, Royce M, Aran B, Whitman G, Ross J, Sneige N, Hortobagyi GN, Pusztai L: Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer.J Clin Oncol 22:2284–2293, 2004.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genome Center, Cancer Institute (Japanese Foundation for Cancer Research), 3-10-6, Ariake, Koto-ku, 135-8550, Tokyo, Japan

    Koichi Nagasaki & Yoshio Miki

  2. Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Japan

    Yoshio Miki

Authors
  1. Koichi Nagasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshio Miki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koichi Nagasaki.

About this article

Cite this article

Nagasaki, K., Miki, Y. Gene expression profiling of breast cancer. Breast Cancer 13, 2–7 (2006). https://doi.org/10.2325/jbcs.13.2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.2325/jbcs.13.2

Key words

Search

Navigation